Baxter International Inc (BAX)
39.96
-0.97
(-2.37%)
USD |
NYSE |
Apr 25, 13:23
Baxter International Price to Book Value: 2.415 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 24, 2024 | 2.474 |
April 23, 2024 | 2.479 |
April 22, 2024 | 2.442 |
April 19, 2024 | 2.386 |
April 18, 2024 | 2.396 |
April 17, 2024 | 2.389 |
April 16, 2024 | 2.392 |
April 15, 2024 | 2.420 |
April 12, 2024 | 2.438 |
April 11, 2024 | 2.546 |
April 10, 2024 | 2.538 |
April 09, 2024 | 2.589 |
April 08, 2024 | 2.554 |
April 05, 2024 | 2.576 |
April 04, 2024 | 2.577 |
April 03, 2024 | 2.616 |
April 02, 2024 | 2.594 |
April 01, 2024 | 2.632 |
March 28, 2024 | 2.583 |
March 27, 2024 | 2.580 |
March 26, 2024 | 2.511 |
March 25, 2024 | 2.526 |
March 22, 2024 | 2.535 |
March 21, 2024 | 2.539 |
March 20, 2024 | 2.528 |
Date | Value |
---|---|
March 19, 2024 | 2.536 |
March 18, 2024 | 2.511 |
March 15, 2024 | 2.515 |
March 14, 2024 | 2.540 |
March 13, 2024 | 2.580 |
March 12, 2024 | 2.592 |
March 11, 2024 | 2.628 |
March 08, 2024 | 2.646 |
March 07, 2024 | 2.629 |
March 06, 2024 | 2.598 |
March 05, 2024 | 2.563 |
March 04, 2024 | 2.569 |
March 01, 2024 | 2.479 |
February 29, 2024 | 2.473 |
February 28, 2024 | 2.512 |
February 27, 2024 | 2.530 |
February 26, 2024 | 2.538 |
February 23, 2024 | 2.572 |
February 22, 2024 | 2.539 |
February 21, 2024 | 2.552 |
February 20, 2024 | 2.525 |
February 16, 2024 | 2.491 |
February 15, 2024 | 2.474 |
February 14, 2024 | 2.396 |
February 13, 2024 | 2.395 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.986
Minimum
Oct 12 2023
6.216
Maximum
Apr 20 2020
4.434
Average
4.673
Median
Price to Book Value Benchmarks
Becton Dickinson & Co | 2.633 |
LeMaitre Vascular Inc | 4.708 |
Integer Holdings Corp | 2.458 |
Outset Medical Inc | 0.9637 |
Perspective Therapeutics Inc | 12.33 |
Price to Book Value Related Metrics
PE Ratio | 7.655 |
PS Ratio | 1.355 |
Price to Free Cash Flow | 19.59 |
Price | 39.96 |
Earnings Yield | 13.06% |
Market Cap | 20.29B |
Operating PE Ratio | 43.20 |
Normalized PE Ratio | 569.77 |